` Comparison: RAP vs DOCS - Alpha Spread

RAP
vs
DOCS

Over the past 12 months, RAP has underperformed DOCS, delivering a return of 0% compared to the DOCS's 67% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RAP
DOCS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

RAP Intrinsic Value
HIDDEN
Show
DOCS Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Resapp Health Ltd
ASX:RAP
0.205 AUD
Doximity Inc
NYSE:DOCS
24.025 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RAP, DOCS

RAP
DOCS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Resapp Health Ltd
Revenue
Doximity Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
RAP, DOCS

RAP
DOCS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Resapp Health Ltd
ASX:RAP
Doximity Inc
NYSE:DOCS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

RAP
0%
DOCS
89.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

Operating Margin

RAP
-276.2%
DOCS
37.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

Net Margin

RAP
-282.1%
DOCS
37.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

FCF Margin

RAP
-166%
DOCS
48.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

ROE

RAP
-171.1%
DOCS
23.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

ROA

RAP
-93%
DOCS
20.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

ROIC

RAP
-316.6%
DOCS
55.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

ROCE

RAP
-158.6%
DOCS
23.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Resapp Health Ltd
Doximity Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
RAP, DOCS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RAP, DOCS

Performance Gap Between RAP and DOCS
HIDDEN
Show

Performance By Year
RAP, DOCS

Loading
RAP
DOCS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RAP to other stocks
0R00
Cerner Corp
C
VEEV
Veeva Systems Inc
PME
Pro Medicus Ltd
2413
M3 Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett